TY  - GEN
AU  - Nunes, Baltazar
AU  - Humphreys, James
AU  - Nicolay, Nathalie
AU  - Braeye, Toon
AU  - Van Evercooren, Izaak
AU  - Holm Hansen, Christian
AU  - Moustsen-Helms, Ida Rask
AU  - Sacco, Chiara
AU  - Fabiani, Massimo
AU  - Castilla, Jesús
AU  - Martínez-Baz, Iván
AU  - Meijerink, Hinta
AU  - Machado, Ausenda
AU  - Soares, Patricia
AU  - Ljung, Rickard
AU  - Pihlström, Nicklas
AU  - Nardone, Anthony
AU  - Bacci, Sabrina
AU  - Monge Corella, Susana
AU  - VEBIS-EHR Working Group
PY  - 2024
DO  - 10.1080/14760584.2024.2428800
SN  - 1476-0584
UR  - https://hdl.handle.net/20.500.12105/25940
AB  - Background: We aimed to estimate XBB.1.5 vaccine effectiveness (VE) against COVID-19-related hospitalizations and deaths during BA.2.86/JN.1 predominance, among EU/EEA individuals with ≥65-years. Research design and methods: We linked electronic...
LA  - eng
PB  - Taylor & Francis
KW  - COVID-19
KW  - SARS-CoV-2
KW  - Cohort design
KW  - Electronic health records
KW  - Hospitalization
KW  - Multi-country study
KW  - Vaccine effectiveness
KW  - Aged
KW  - Aged, 80 and over
KW  - COVID-19 Vaccines
KW  - COVID-19
KW  - Cohort Studies
KW  - Electronic Health Records
KW  - Europe
KW  - Hospitalization
KW  - Humans
KW  - SARS-CoV-2
KW  - Vaccination
KW  - Vaccine Efficacy
TI  - Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
TY  - research article
ER  -